2021-12-08-世界卫生组织-8th_Facilitation_Council_Financing_Framework_11页_1mb

报告摘要

Event: 8th ACT Facilitation Council, 9 December 2021.
Theme: ACT Now. ACT Together: Accelerating the end of the COVID-19 crisis.
Key Objective: Confirm overall investment required for vaccines, diagnostics, therapeutics, and health systems response under ACT-A and complementary needs; Identify and size financing sources.

Overall Funding Need (ACT-A): The new 12-month Strategic Plan & Budget outlines a total funding need of US$23.4 billion.
Burden Sharing: The framework is based on burden-sharing principles, proposing equal contributions from high-income countries (HICs), considering adjustments based on country-specific risk factors (debt distress) and COVAX participation.
Need for Funds: Urgent call for funding ahead of a potential pledging event in early 2022 to meet the strategic plan and budget needs.

ACT-A Budget (US$23.4bn):
- Covers direct procurement needs for vaccines (~$19bn), diagnostics (~$3bn), and therapeutics ($0.8bn) as well as agency technical assistance, etc.
- Does NOT cover: Additional domestic procurement (up to ~US$29.3bn), domestic resource mobilization costs, public health & social measures ($~US$3.6bn), domestic in-kind contributions (goods, workforce), or manufacturing needs.
Total Procurement Needs (All Tools): The ACT-A budget is part of a larger procurement pool (US$29.3bn minimum) to reach global coverage targets. Complementary needs (US$16.8bn ask for domestic resources + MDB concessional funding) are outside ACT-A's direct procurement budget (~US$23.4bn) but necessary to meet targets.
Fair Share Principle: Countries are asked to contribute based on a grant financing need of US$16.8bn (covering critical procurement and public good R&D). Donors are urged to commit generously, maintaining aid levels despite budget pressures.

Achieving equity in access, especially for vulnerable LICs and remote/underserved populations.
Relying on continued donor commitment and bipartite funding for ACT-A agencies.
Ensuring technology transfer and financing access for LMIC manufacturing capabilities.
Meeting funding requirements is crucial for ACT-A's continued operations and global COVID response goals.

Financial Council mandated contributing countries to support efforts, grouped in specific categories threshold (HICs, EU, Non-EU OECD, etc.), with fair shares requiring proportional contribution.
Fair shares were provided for key countries and groups, showing the required contribution relative to the US$16.8bn grant target (with a +20% buffer) (e.g., United States US$5.96bn, EU collectively with thresholds).

展开完整摘要